Physician profile
Jerry Capote
NPI 1740449545
$585.04
in general payments reported to CMS, 2019-2025
10 companies · $49.75 in 2025
The $49.75 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.16 · 2021: $253 · 2022: $139 · 2023: $21.27 · 2024: $104 · 2025: $49.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $185.17 | 2021 | |
| Alexion Pharmaceuticals, INC. | $112.14 | 2022 | |
| Intuitive Surgical, INC. | $67.41 | 2021 | |
| Atricure, INC. | $65.87 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $50.80 | 2024 | Venaseal |
| Abbvie INC. | $27.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.27 | 2023 | |
| Argenx US, INC. | $20.99 | 2024 | Vyvgart Hytrulo |
| Genentech USA, INC. | $18.16 | 2019 | |
| Glaxosmithkline, LLC. | $16.06 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Capote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.